Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125705771 | 12570577 | 1 | I | 20160705 | 20160719 | 20160719 | EXP | JP-CORDEN PHARMA LATINA S.P.A.-JP-2016COR000191 | CORDEN | SHINTANI D, YOSHIDA H, IMAI Y, FUJIWARA K. ACUTE PANCREATITIS INDUCED BY PACLITAXEL AND CARBOPLATIN THERAPY IN AN OVARIAN CANCER PATIENT. EUR J GYNAECOL ONCOL. 2016;37(2):286-287 | 46.00 | YR | F | Y | 0.00000 | 20160719 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125705771 | 12570577 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | AUC 6 OVER ONE HOUR, EVERY THREE WEEKS | Y | 19880 | ||||||||||
| 125705771 | 12570577 | 2 | SS | PACLITAXEL. | PACLITAXEL | 1 | 175 MG/M2, OVER THREE HOURS, EVERY THREE WEEKS | Y | 0 | 175 | MG/M**2 | ||||||||
| 125705771 | 12570577 | 3 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | U | 0 | ||||||||||
| 125705771 | 12570577 | 4 | C | RANITIDINE. | RANITIDINE | 1 | UNK | U | 0 | ||||||||||
| 125705771 | 12570577 | 5 | C | PALONOSETRON | PALONOSETRON | 1 | UNK | U | 0 | ||||||||||
| 125705771 | 12570577 | 6 | C | APREPITANT. | APREPITANT | 1 | UNK | U | 0 | ||||||||||
| 125705771 | 12570577 | 7 | C | CHLORPHENIRAMINE /00072501/ | CHLORPHENIRAMINE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125705771 | 12570577 | 1 | Ovarian epithelial cancer |
| 125705771 | 12570577 | 2 | Ovarian epithelial cancer |
| 125705771 | 12570577 | 3 | Premedication |
| 125705771 | 12570577 | 4 | Premedication |
| 125705771 | 12570577 | 5 | Premedication |
| 125705771 | 12570577 | 6 | Premedication |
| 125705771 | 12570577 | 7 | Premedication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125705771 | 12570577 | HO |
| 125705771 | 12570577 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125705771 | 12570577 | Abdominal distension | |
| 125705771 | 12570577 | Abdominal pain | |
| 125705771 | 12570577 | Abdominal tenderness | |
| 125705771 | 12570577 | Amylase increased | |
| 125705771 | 12570577 | Blood lactate dehydrogenase increased | |
| 125705771 | 12570577 | Lipase increased | |
| 125705771 | 12570577 | Nausea | |
| 125705771 | 12570577 | Neutropenia | |
| 125705771 | 12570577 | Oedematous pancreatitis | |
| 125705771 | 12570577 | Pancreatic enlargement | |
| 125705771 | 12570577 | Pancreatitis acute | |
| 125705771 | 12570577 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |